سعر يوريبان اكس ار Uripan x.r‏ 10مجم 30 قرص 2026

Oxybutynin 10 mg extended-release tablet (adwia).

• Anticholinergic adverse reactions, most commonly dry mouth, constipation, diarrhoea, headache, somnolence and dizziness.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Urinary retention, gastric retention and other severe decreased GI motility conditions, uncontrolled narrow-angle glaucoma (and patients at risk of these); hypersensitivity to oxybutynin or components.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Angioedema of face, lips, tongue or larynx reported, sometimes after the first dose; discontinue promptly if it occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Anticholinergic CNS effects (hallucinations, agitation, confusion, somnolence) may occur; caution in dementia treated with cholinesterase inhibitors, Parkinson's disease, myasthenia gravis, autonomic neuropathy, bladder outflow obstruction, GI obstruction and reflux.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Other anticholinergic drugsMay increase frequency/severity of dry mouth, constipation, somnolence and other anticholinergic effects.DailyMed (U.S. National Library of Medicine)
• Strong CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin)May increase oxybutynin exposure; use caution.DailyMed (U.S. National Library of Medicine)

• No adequate data on use in pregnant women to evaluate drug-associated risk of birth defects, miscarriage or adverse outcomes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk, effects on the breastfed infant or milk production; weigh benefits of breastfeeding against maternal need.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)